Structure-based drug design with geometric deep learning

• URL: http://arxiv.org/abs/2210.11250v1
• Date: Wed, 19 Oct 2022 16:21:48 GMT
• Title: Structure-based drug design with geometric deep learning
• Authors: Clemens Isert, Kenneth Atz, Gisbert Schneider
• Abstract summary: Structure-based drug design uses three-dimensional geometric information of macromolecules such as proteins or nucleic acids to identify suitable. geometric deep learning, an emerging concept of neural-network-based machine learning, has been applied to macromolecular structures. This review provides an overview of the recent applications of geometric deep learning in bioorganic and medicinal chemistry, highlighting its potential for structure-based drug discovery and design.
• Score: 0.0
• License: http://creativecommons.org/licenses/by-sa/4.0/
• Abstract: Structure-based drug design uses three-dimensional geometric information of macromolecules, such as proteins or nucleic acids, to identify suitable ligands. Geometric deep learning, an emerging concept of neural-network-based machine learning, has been applied to macromolecular structures. This review provides an overview of the recent applications of geometric deep learning in bioorganic and medicinal chemistry, highlighting its potential for structure-based drug discovery and design. Emphasis is placed on molecular property prediction, ligand binding site and pose prediction, and structure-based de novo molecular design. The current challenges and opportunities are highlighted, and a forecast of the future of geometric deep learning for drug discovery is presented.

Related papers

• GraphXForm: Graph transformer for computer-aided molecular design with application to extraction [73.1842164721868]
  We present GraphXForm, a decoder-only graph transformer architecture, which is pretrained on existing compounds and then fine-tuned. We evaluate it on two solvent design tasks for liquid-liquid extraction, showing that it outperforms four state-of-the-art molecular design techniques.
  arXiv  Detail & Related papers  (2024-11-03T19:45:15Z)
• Geometric Deep Learning for Structure-Based Drug Design: A Survey [83.87489798671155]
  Structure-based drug design (SBDD) leverages the three-dimensional geometry of proteins to identify potential drug candidates. Recent advancements in geometric deep learning, which effectively integrate and process 3D geometric data, have significantly propelled the field forward.
  arXiv  Detail & Related papers  (2023-06-20T14:21:58Z)
• Symmetry-Informed Geometric Representation for Molecules, Proteins, and Crystalline Materials [66.14337835284628]
  We propose a platform, coined Geom3D, which enables benchmarking the effectiveness of geometric strategies. Geom3D contains 16 advanced symmetry-informed geometric representation models and 14 geometric pretraining methods over 46 diverse datasets.
  arXiv  Detail & Related papers  (2023-06-15T05:37:25Z)
• An Equivariant Generative Framework for Molecular Graph-Structure Co-Design [54.92529253182004]
  We present MolCode, a machine learning-based generative framework for underlineMolecular graph-structure underlineCo-design. In MolCode, 3D geometric information empowers the molecular 2D graph generation, which in turn helps guide the prediction of molecular 3D structure. Our investigation reveals that the 2D topology and 3D geometry contain intrinsically complementary information in molecule design.
  arXiv  Detail & Related papers  (2023-04-12T13:34:22Z)
• Implicit Geometry and Interaction Embeddings Improve Few-Shot Molecular Property Prediction [53.06671763877109]
  We develop molecular embeddings that encode complex molecular characteristics to improve the performance of few-shot molecular property prediction. Our approach leverages large amounts of synthetic data, namely the results of molecular docking calculations. On multiple molecular property prediction benchmarks, training from the embedding space substantially improves Multi-Task, MAML, and Prototypical Network few-shot learning performance.
  arXiv  Detail & Related papers  (2023-02-04T01:32:40Z)
• Structure-based drug discovery with deep learning [0.0]
  Artificial intelligence (AI) in the form of deep learning bears promise for drug discovery and chemical biology. This review summarizes the most prominent algorithmic concepts in structure-based deep learning for drug discovery.
  arXiv  Detail & Related papers  (2022-12-26T20:52:26Z)
• Scalable Fragment-Based 3D Molecular Design with Reinforcement Learning [68.8204255655161]
  We introduce a novel framework for scalable 3D design that uses a hierarchical agent to build molecules. In a variety of experiments, we show that our agent, guided only by energy considerations, can efficiently learn to produce molecules with over 100 atoms.
  arXiv  Detail & Related papers  (2022-02-01T18:54:24Z)
• Geometric Deep Learning on Molecular Representations [0.0]
  Geometric deep learning (GDL) is based on neural network architectures that incorporate and process symmetry information. This review provides a structured and harmonized overview of molecular GDL, highlighting its applications in drug discovery, chemical synthesis prediction, and quantum chemistry. Emphasis is placed on the relevance of the learned molecular features and their complementarity to well-established molecular descriptors.
  arXiv  Detail & Related papers  (2021-07-26T09:23:43Z)
• GeoT: A Geometry-aware Transformer for Reliable Molecular Property Prediction and Chemically Interpretable Representation Learning [16.484048833163282]
  We introduce a novel Transformer-based framework for molecular representation learning, named the Geometry-aware Transformer (GeoT) GeoT learns molecular graph structures through attention-based mechanisms specifically designed to offer reliable interpretability, as well as molecular property prediction. Our comprehensive experiments, including an empirical simulation, reveal that GeoT effectively learns the chemical insights into molecular structures, bridging the gap between artificial intelligence and molecular sciences.
  arXiv  Detail & Related papers  (2021-06-29T15:47:18Z)
• Generative chemistry: drug discovery with deep learning generative models [0.0]
  This paper reviews the latest advances in generative chemistry which relies on generative modeling to expedite the drug discovery process. The detailed discussions on utilizing cutting-edge generative architectures, including recurrent neural network, variational autoencoder, adversarial autoencoder, and generative adversarial network for compound generation are focused.
  arXiv  Detail & Related papers  (2020-08-20T14:38:21Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.